1 Study Coverage 1.1 Congestive Heart Failure (CHF) Treatment Devices Product Introduction 1.2 Market by Type 1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type 1.2.2 Cardiac Resynchronization Therapy (CRT) 1.2.3 Implantable Cardioverter Defibrillators (ICDs) 1.3 Market by Application 1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application 1.3.2 Left Ventricular Assist Device (LVAD) 1.3.3 Right Ventricular Assist Device (RVAD) 1.3.4 Biventricular Assist Device (BIVAD) 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size, Estimates and Forecasts 2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2016-2027 2.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales 2016-2027 2.2 Global Congestive Heart Failure (CHF) Treatment Devices, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Congestive Heart Failure (CHF) Treatment Devices Historical Market Size by Region (2016-2021) 2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2022-2027) 2.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2022-2027) 3 Global Congestive Heart Failure (CHF) Treatment Devices Competitor Landscape by Players 3.1 Global Top Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Sales 3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturer (2016-2021) 3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Revenue 3.2.1 Key Congestive Heart Failure (CHF) Treatment Devices Manufacturers Covered: Ranking by Revenue 3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2016-2021) 3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Congestive Heart Failure (CHF) Treatment Devices Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2020 3.2.6 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Manufacturers 3.4 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution, Product Types 3.4.1 Congestive Heart Failure (CHF) Treatment Devices Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type 3.4.3 Date of International Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Type (2016-2021) 4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021) 4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2016-2021) 4.1.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Type (2022-2027) 4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2022-2027) 4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2022-2027) 4.2.3 Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Application (2016-2021) 5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021) 5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2016-2021) 5.1.3 Congestive Heart Failure (CHF) Treatment Devices Price by Application (2016-2021) 5.2 Congestive Heart Failure (CHF) Treatment Devices Market Size Forecast by Application (2022-2027) 5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2022-2027) 5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2022-2027) 5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2016-2027 6.1.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales YoY Growth 2016-2027 6.1.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue YoY Growth 2016-2027 6.1.3 Japan Congestive Heart Failure (CHF) Treatment Devices Market Share in Global Market 2016-2027 6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size by Players (International and Local Players) 6.2.1 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Sales (2016-2021) 6.2.2 Japan Top Congestive Heart Failure (CHF) Treatment Devices Players by Revenue (2016-2021) 6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Type (2016-2021) 6.3.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2021) 6.3.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2016-2021) 6.3.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Type (2016-2021) 6.4 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2022-2027) 6.4.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2022-2027) 6.4.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2022-2027) 6.5 Japan Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Application (2016-2021) 6.5.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2021) 6.5.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2016-2021) 6.5.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price by Application (2016-2021) 6.6 Japan Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2022-2027) 6.6.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2022-2027) 6.6.3 Japan Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2022-2027) 7 North America 7.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2016-2027 7.2 North America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 7.2.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) 7.2.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2016-2027 8.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Region 8.2.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021) 8.2.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2016-2027 9.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 9.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) 9.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2016-2027 10.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 10.2.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) 10.2.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country 11.2.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) 11.2.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Abiomed 12.1.1 Abiomed Corporation Information 12.1.2 Abiomed Description and Business Overview 12.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.1.5 Abiomed Recent Development 12.2 Berlin Heart GmbH 12.2.1 Berlin Heart GmbH Corporation Information 12.2.2 Berlin Heart GmbH Description and Business Overview 12.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.2.5 Berlin Heart GmbH Recent Development 12.3 Biotronik SE & Co. KG 12.3.1 Biotronik SE & Co. KG Corporation Information 12.3.2 Biotronik SE & Co. KG Description and Business Overview 12.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.3.5 Biotronik SE & Co. KG Recent Development 12.4 Boston Scientific Corporation 12.4.1 Boston Scientific Corporation Corporation Information 12.4.2 Boston Scientific Corporation Description and Business Overview 12.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.4.5 Boston Scientific Corporation Recent Development 12.5 HeartWare International 12.5.1 HeartWare International Corporation Information 12.5.2 HeartWare International Description and Business Overview 12.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.5.5 HeartWare International Recent Development 12.6 Jarvik Heart 12.6.1 Jarvik Heart Corporation Information 12.6.2 Jarvik Heart Description and Business Overview 12.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.6.5 Jarvik Heart Recent Development 12.7 LivaNova PLC 12.7.1 LivaNova PLC Corporation Information 12.7.2 LivaNova PLC Description and Business Overview 12.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.7.5 LivaNova PLC Recent Development 12.8 Medtronic 12.8.1 Medtronic Corporation Information 12.8.2 Medtronic Description and Business Overview 12.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.8.5 Medtronic Recent Development 12.9 ReliantHeart 12.9.1 ReliantHeart Corporation Information 12.9.2 ReliantHeart Description and Business Overview 12.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.9.5 ReliantHeart Recent Development 12.10 Abbott 12.10.1 Abbott Corporation Information 12.10.2 Abbott Description and Business Overview 12.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.10.5 Abbott Recent Development 12.11 Abiomed 12.11.1 Abiomed Corporation Information 12.11.2 Abiomed Description and Business Overview 12.11.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered 12.11.5 Abiomed Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends 13.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers 13.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges 13.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Congestive Heart Failure (CHF) Treatment Devices Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Cardiac Resynchronization Therapy (CRT) Table 3. Major Manufacturers of Implantable Cardioverter Defibrillators (ICDs) Table 4. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Regions (2016-2021) & (K Units) Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Regions (2016-2021) Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Region (2022-2027) Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Manufacturers (2016-2021) (K Units) Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Congestive Heart Failure (CHF) Treatment Devices Manufacturers by Revenue (US$ Million) in 2020 Table 16. Congestive Heart Failure (CHF) Treatment Devices Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2016-2021) Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2020) Table 20. Key Manufacturers Congestive Heart Failure (CHF) Treatment Devices Price (2016-2021) (USD/Unit) Table 21. Congestive Heart Failure (CHF) Treatment Devices Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Congestive Heart Failure (CHF) Treatment Devices Product Type Table 23. Date of International Manufacturers Enter into Congestive Heart Failure (CHF) Treatment Devices Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2016-2021) (K Units) Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2016-2021) Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2016-2021) (US$ Million) Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2016-2021) Table 29. Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Type (2022-2027) Table 32. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 35. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2016-2021) (K Units) Table 36. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2016-2021) Table 37. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2016-2021) (US$ Million) Table 38. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2016-2021) Table 39. Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 40. Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Application (2022-2027) Table 42. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Congestive Heart Failure (CHF) Treatment Devices Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 45. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) of Key Companies (2016-2021) Table 46. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Company (2016-2021) Table 47. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Company (2016-2021) Table 48. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Company (2016-2021) Table 49. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2016-2021) Table 50. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2016-2021) Table 51. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. Japan Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Type (2016-2021) Table 53. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2022-2027) Table 54. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2022-2027) Table 55. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2022-2027) Table 57. Japan Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Type (2022-2027) Table 58. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2016-2021) Table 59. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2016-2021) Table 60. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. Japan Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Application (2016-2021) Table 62. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2022-2027) Table 63. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2022-2027) Table 64. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2022-2027) Table 66. Japan Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Application (2022-2027) Table 67. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 68. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 69. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2021) Table 75. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 76. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 77. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 79. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 80. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2016-2021) Table 87. Abiomed Corporation Information Table 88. Abiomed Description and Business Overview Table 89. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 90. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Table 91. Abiomed Recent Development Table 92. Berlin Heart GmbH Corporation Information Table 93. Berlin Heart GmbH Description and Business Overview Table 94. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 95. Berlin Heart GmbH Product Table 96. Berlin Heart GmbH Recent Development Table 97. Biotronik SE & Co. KG Corporation Information Table 98. Biotronik SE & Co. KG Description and Business Overview Table 99. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 100. Biotronik SE & Co. KG Product Table 101. Biotronik SE & Co. KG Recent Development Table 102. Boston Scientific Corporation Corporation Information Table 103. Boston Scientific Corporation Description and Business Overview Table 104. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 105. Boston Scientific Corporation Product Table 106. Boston Scientific Corporation Recent Development Table 107. HeartWare International Corporation Information Table 108. HeartWare International Description and Business Overview Table 109. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 110. HeartWare International Product Table 111. HeartWare International Recent Development Table 112. Jarvik Heart Corporation Information Table 113. Jarvik Heart Description and Business Overview Table 114. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 115. Jarvik Heart Product Table 116. Jarvik Heart Recent Development Table 117. LivaNova PLC Corporation Information Table 118. LivaNova PLC Description and Business Overview Table 119. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 120. LivaNova PLC Product Table 121. LivaNova PLC Recent Development Table 122. Medtronic Corporation Information Table 123. Medtronic Description and Business Overview Table 124. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 125. Medtronic Product Table 126. Medtronic Recent Development Table 127. ReliantHeart Corporation Information Table 128. ReliantHeart Description and Business Overview Table 129. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 130. ReliantHeart Product Table 131. ReliantHeart Recent Development Table 132. Abbott Corporation Information Table 133. Abbott Description and Business Overview Table 134. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 135. Abbott Product Table 136. Abbott Recent Development Table 137. Congestive Heart Failure (CHF) Treatment Devices Market Trends Table 138. Congestive Heart Failure (CHF) Treatment Devices Market Drivers Table 139. Congestive Heart Failure (CHF) Treatment Devices Market Challenges Table 140. Congestive Heart Failure (CHF) Treatment Devices Market Restraints Table 141. Congestive Heart Failure (CHF) Treatment Devices Customers List Table 142. Congestive Heart Failure (CHF) Treatment Devices Distributors List Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2020 & 2027 Figure 3. Cardiac Resynchronization Therapy (CRT) Product Picture Figure 4. Implantable Cardioverter Defibrillators (ICDs) Product Picture Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2020 & 2027 Figure 6. Left Ventricular Assist Device (LVAD) Figure 7. Right Ventricular Assist Device (RVAD) Figure 8. Biventricular Assist Device (BIVAD) Figure 9. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered Figure 10. Global Congestive Heart Failure (CHF) Treatment Devices Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Market Size 2016-2027 (US$ Million) Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales 2016-2027 (K Units) Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2016-2021) Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2020 Figure 16. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2016-2021) Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in 2020 Figure 18. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Congestive Heart Failure (CHF) Treatment Devices Revenue in 2020 Figure 20. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2016-2021) Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2020 Figure 23. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2016-2021) Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type in 2020 Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2016-2021) Figure 26. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2020 Figure 27. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2016-2021) Figure 28. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application in 2020 Figure 29. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2016-2027 (K Units) Figure 30. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. Japan Congestive Heart Failure (CHF) Treatment Devices Market Share in Global Market 2016-2027 Figure 32. Japan 5 and 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players Market Share by Revenue in Congestive Heart Failure (CHF) Treatment Devices in 2020 Figure 33. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2016-2021) Figure 34. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate by Type in 2016 & 2020 Figure 35. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2016-2021) Figure 36. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2016-2021 (K Units) Figure 38. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2020 Figure 40. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2020 Figure 41. U.S. Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 42. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 44. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2016-2021 (K Units) Figure 46. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2020 Figure 48. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2020 Figure 49. Germany Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 50. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 52. France Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 54. U.K. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 56. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 58. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2016-2021 (K Units) Figure 60. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region in 2020 Figure 62. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region in 2020 Figure 63. China Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 64. China Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 66. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 68. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 70. India Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 72. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 74. Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 76. Indonesia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 78. Thailand Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 80. Malaysia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 82. Philippines Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 84. Vietnam Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2016-2021 (K Units) Figure 86. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2020 Figure 88. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2020 Figure 89. Mexico Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 90. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 92. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 94. Argentina Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate 2016-2021 (K Units) Figure 96. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country in 2020 Figure 99. Turkey Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 100. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 102. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. U.A.E Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2016-2021) (K Units) Figure 104. U.A.E Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Congestive Heart Failure (CHF) Treatment Devices Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Abiomed Berlin Heart GmbH Biotronik SE & Co. KG Boston Scientific Corporation HeartWare International Jarvik Heart LivaNova PLC Medtronic ReliantHeart Abbott